迪瑞医疗收盘下跌1.06%，滚动市盈率106.87倍，总市值38.26亿元

Company Overview - Dirui Medical's closing price on July 4 was 14.03 yuan, down 1.06%, with a rolling PE ratio of 106.87 times and a total market capitalization of 3.826 billion yuan [1] - The company ranks 106th in the medical device industry, which has an average PE ratio of 51.05 times and a median of 36.62 times [1][2] - Dirui Medical specializes in the research, production, marketing, and service of medical testing instruments and related reagents, with key products including urine analysis, biochemical analysis, and blood cell analysis [1] Financial Performance - In the first quarter of 2025, Dirui Medical reported revenue of 182 million yuan, a year-on-year decrease of 72.47%, and a net profit of 15.68 million yuan, down 87.13% year-on-year, with a gross profit margin of 42.78% [1] - The company holds 213 patents, including 136 invention patents and 96 software copyrights [1] Market Activity - On July 4, Dirui Medical experienced a net outflow of 1.1247 million yuan in principal funds, although the overall trend over the past five days showed a net inflow of 9.9255 million yuan [1]